Serum CA125, CA199 and CEA combined detection for epithelial ovarian cancer diagnosis: A meta-analysis

Guo Junhong; Yu Jiangtao; Song Xiaojie; Mi Haixia

doi:10.1515/med-2017-0020

Open Medicine (May 2017)

Serum CA125, CA199 and CEA combined detection for epithelial ovarian cancer diagnosis: A meta-analysis

Guo Junhong,
Yu Jiangtao,
Song Xiaojie,
Mi Haixia

Affiliations

Guo Junhong: Department of Obstetrics and GynecologyWuhan Children’ Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science&Technology, Wuhan Hubei Province430016 P.R. China
Yu Jiangtao: Department of Obstetrics and Gynecology1st Affiliated Hospital of Wenzhou Medical UniversityWenzhou Zhejiang Province325035 P.R.China
Song Xiaojie: Department of Obstetrics and GynecologyWuhan Children’ Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science&Technology, Wuhan Hubei Province430016 P.R. China
Mi Haixia: Department of Obstetrics and Gynecology of traditional Chinese Medicine, Wenzhou People’s Hospital, Wenzhou Zhejiang Province325000 P.R. China

DOI: https://doi.org/10.1515/med-2017-0020
Journal volume & issue: Vol. 12, no. 1
pp. 131 – 137

Abstract

Read online

To evaluate the diagnostic value of combination detection of serum cancer antigen 125 (CA125), carbohydrate antigen 19-9 (CA199) and carci noembryonic antigen(CEA) in patients with epithelial ovarian cancer by pooling the open published studies according to meta-analysis method.

Published in Open Medicine

ISSN: 2391-5463 (Online)
Publisher: De Gruyter
Country of publisher: Poland
LCC subjects: Medicine
Website: https://www.degruyter.com/journal/key/med/html

About the journal

Abstract

Keywords